Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05610514 · ClinicalTrials.gov registry record · Phase 2
Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes
A Phase 2 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT05610514 is a Phase 2 study that has completed, run by University of Vermont. The registered enrollment target is 21 participants.
The verdict
NCT05610514, a Phase 2 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of e-cigarettes and continued smoking on pulmonary and cardiac outcomes in a population with established pulmonary disease.
Interventions
- BEHAVIORAL Financial Incentives
- OTHER E-Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2023-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05610514
The ClinicalTrials.gov registry entry for NCT05610514 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Financial Incentives is the first listed.
NCT05610514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05610514 about?
NCT05610514 is a clinical study titled "Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes". The purpose of this study is to compare the effects of e-cigarettes and continued smoking on pulmonary and cardiac outcomes in a population with established pulmonary disease.
What is the current status of trial NCT05610514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2022-04-28. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT05610514?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), E-Cigarette (OTHER).
Who is sponsoring clinical trial NCT05610514?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.